Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma-Reference-Cited by-同舟云学术

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma

Published:1999-05 Issue:5 Volume:10 Page:527-529
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Przepiorka D.,van Besien K.,Khouri I.,Hagemeister F.,Samuels B.,Folloder J.,Ueno N.T.,Molldrem J.,Mehra R.,Körbling M.,Giralt S.,Gajewski J.,Donato M.,Cleary K.,Claxton D.,Braunschweig I.,Andersson B.,Anderlini P.,Champlin R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/10/5/527/19477447/10-5-527.pdf

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparative Regimens Used in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapies;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma;Leukemia & Lymphoma;2021-02-13

3. BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions;Biology of Blood and Marrow Transplantation;2020-12

4. BEAM-Modified Conditioning Therapy with Cisplatin+Dexamethasone Instead of Carmustine Prior to Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma;Annals of Transplantation;2019-10-22

5. Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results;Biology of Blood and Marrow Transplantation;2019-07